Skip to main content
. 2017 Sep 18;6(9):e005967. doi: 10.1161/JAHA.117.005967

Table 1.

Baseline Variable Summary Statistics: SHHEC Participants by Sex, Aged ≥30, and Free of CVD

Values Obtained Men Women All
Number of participants 15 737 7552 8185 15 737
Personal
Ageb 15 737 49.0 (8.3) 49.0 (8.3) 49.0 (8.3)
Sex,b male% 15 737 100 0 52.0.
Years of education 15 396 11.2 (2.8) 11.1 (2.5) 11.1 (2.6)
Family history of CHD,b % 15 737 25.5 31.8 28.8
SIMD‐socioeconomic scoreb 15 737 28.0 (21.9) 28.6 (22.0) 28.3 (21.9)
ASSIGN cardiovascular risk scoreb 13 444 14.8 (10.6) 9.5 (9.9) 12.1 (10.6)
Smoking
Current tobacco smoker, % 15 737 51.6 40.2 45.7
Cigarettes equivalent,b cigs/d 15 737 9.1 (11.9) 6.6 (9.6) 7.8 (10.83)
Expired carbon monoxide, ppm 15 257 10.6 (12.5) 9.0 (11.5) 9.8 (12.0)
Thiocyanate, μmol/La 13 738a 57.8 (1.99) 58.4 (1.98) 58.1 (1.98)
Cotinine, ng/mL 10 984 128 (171) 103 (152) 115 (162)
Physical measurements
Height, m 15 729 1.73 (0.07) 1.60 (0.06) 1.66 (0.09)
Weight, kg 15 727 77.9 (12.5) 65.9 (12.6) 71.6 (13.9)
Body mass index, kg/m2 15 725 26.0 (3.7) 25.8 (4.8) 25.9 (4.3)
Waist circumference, cm 4061 92.2 (11.6) 80.5 (12.2) 85.9 (13.2)
Waist/hip ratio 4061 0.92 (0.078) 0.79 (0.071) 0.85 (0.096)
SBP,b mm Hg 15 729 134.0 (19.4) 130.5 (21.1) 132.1 (20.4)
DBP, mm Hg 15 729 83.4 (12.0) 79.6 (11.9) 81.4 (12.1)
Pulse pressure, mm Hg 15 729 50.6 (14.1) 50.8 (15.1) 50.7 (14.6)
Pulse rate, bpm 15 661 76.5 (13.3) 78.6 (12.3) 77.6 (12.9)
Diabetes mellitus
Diabetes mellitus,b % 15 737 1.6 1.4 1.5
Glucose, mmol/L (nonfasting) 12 837 5.17 (1.54) 4.92 (1.36) 5.04 (1.46)
Insulin, μU/mL (nonfasting)c 12 281 11.2 (13.2) 8.52 (9.60) 9.83 (11.6)
C‐Peptide, mg/mLa, c 12 365 (13)a 2.41 (1.92) 2.14 (1.82) 2.27 (1.90)
Lipids
Total cholesterol,b mmol/L 14 172 6.23 (1.16) 6.40 (1.30) 6.32 (1.24)
HDL‐cholesterol,b mmol/L 13 460 1.35 (0.37) 1.63 (0.43) 1.49 (0.42)
Non‐HDL‐cholesterol, mmol/L 13 459 4.88 (1.14) 4.78 (1.21) 4.88 (1.18)
Triglycerides, mmol/La 14 158 1.91 (1.77) 1.41 (1.69) 1.64 (1.76)
LDL‐cholesterol, mmol/Lc 10 833 2.65 (1.27) 2.75 (1.19) 2.70 (1.16)
Apolipoprotein A, g/Lc 12 867 1.49 (0.26) 1.64 (0.30) 1.57 (0.29)
Apolipoprotein B, g/Lc 12 866 1.18 (0.30) 1.13 (0.32) 1.15 (0.31)
Lipoprotein (a), mg/dLa, c 12 773 (88)a 9.55 (3.89) 11.81 (3.38) 10.64 (3.64)
Inflammatory
hsC‐reactive protein, mg/La, c 12 847 1.53 (2.99) 1.27 (3.10) 1.39 (3.06)
Fibrinogen, g/L 13 101 2.75 (0.80) 2.86 (0.81) 2.81 (0.81)
Homocysteine, μmol/Lc 12 843 16.0 (6.6) 14.0 (5.7) 14.9 (6.2)
Ferritin, μmol/La, c 12 319 (22)a 103.0 (2.64) 38.0 (2.97) 62.0 (3.14)
Cardiac
hsTroponin I, pg/mLa, c 11 527 (427)a 3.76 (2.60) 2.25 (3.80) 2.97 (3.29)
NT‐pro‐BNP, pg/mLa, c 10 507 31.7 (2.94) 61.5 (2.45) 44.7 (2.83)
Diet related
25‐Hydroxyvitamin D raw, nmol/Lc 11 603 44.3 (22.7) 39.2 (19.7) 41.6 (21.3)
25‐Hydroxyvitamin D adj, nmol/Lc 11 603 44.0 (19.3) 39.4 (17.9) 41.6 (18.7)
Vitamin B12, pg/mLc 12 355 425 (180) 423 (191) 424 (186)
γ‐Glutamyl transferase, units/La 12 835 31.4 (1.92) 18.5 (1.79) 24.1 (1.96)
Renal related
Uric acid, mmol/L 14 178 320 (66) 243 (62) 281 (75)
Creatinine, mmol/L 11 837 95.9 (12.9) 81.4 (11.0) 88.6 (14.0)
Cystatin‐C, mg/Lc 12 868 0.760 (0.143) 0.716 (0.165) 0.738 (0.156)

Missing values are omitted. Percentages are shown for categorical factors. Arithmetic means and standard deviations are shown for continuous variables with some exceptions.aCHD indicates coronary heart disease; CVD, cardiovascular disease; DBP, diastolic blood pressure; HDL, high‐density lipoprotein; SBP, systolic blood pressure; SHHEC, Scottish Heart Health Extended Cohort; SIMD, Scottish Index of Multiple Deprivation.

a

Geometric means and standard deviations because of positive skew. For these geometric calculations any 0 values (number in parentheses) are set to 0.01 units.

b

ASSIGN risk score factor.

c

Assayed in the MORGAM/BiomarCaRE project after long‐term storage of serum at −40°C.